Selected as ‘2021 Medical Data Centered Hospital’, leading future medicine
Creating an ecosystem for medical big data industry, academia, research, and disease joint research
“We will nourish the development of future medicine by creating an innovative data ecosystem that is intensive with professional medical big data.”
Hallym University Sacred Heart Hospital is carrying out national projects for the development of new artificial intelligence drugs based on medical big data in the era of digital transformation, customized cancer prediction models, and new medical technologies.
Sungsim Hospital was selected as the new host institution in the ‘2021 Medical Data Centered Hospital Support Project’ hosted by the Ministry of Health and Welfare on March 10. The Ministry of Health and Welfare identified the amount of data retained, the size of the institution, the capacity for management and utilization, the cumulative total of more than 1 million patients, and the plan to establish specialized information (DB) for each specialized disease, and selected it through evaluation and on-site inspection.
Sacred Heart Hospital is responsible for the research institute in charge of this project. Hangil Eye Hospital) and a consortium will be provided to receive 1.5 billion won worth of project expenses until December 15, 2021.
The medical data-centered hospital support project was designed to improve medical quality by linking, opening, and combining clinical medical big data accumulated by hospitals, and to create an ecosystem of data utilization so that it can be used for joint research in industry, academia, research, and disease. . The contents of the project are ▲ Establishment of a safe health care data utilization environment ▲ Expansion of data standard distribution and establishment of the basis for utilization ▲ Promotion of specialized data for each field such as the development of artificial intelligence new drugs and major diseases of cancer data ▲ Data set definition for medical data utilization, new technology, artificial intelligence, etc. It is such as promoting research for development.
Through this project, Seongshim Hospital will carry out ▲data production ▲data management and information security ▲data quality management ▲data utilization and opening (the goal of building its own medical big data portal and cloud-based platform).
In particular, Sungshim Hospital will focus on building a dataset by specializing unrefined data (atypical data) by cancer, cardiovascular disease, respiratory disease, and specialized disease (ophthalmology, otorhinolaryngology).
When a data set for each disease is established, it is possible to innovate medical quality in a variety of ways. First, it is possible to discover a corona risk prediction model, develop diagnosis and treatment, and develop a customized survival rate and prognosis prediction model for cancer patients. In addition, when researching the development of new drugs such as cancer and sleep disorders, research efficiency and effects can be improved based on artificial intelligence, and side effects and effects of different drugs can be predicted for each patient.
It is also used in medical device development research. Based on the biosignal biomarker, it is possible to develop a technology that allows artificial intelligence to automatically screen and diagnose diseases or read tests. It is also used in digital healthcare research. By standardizing the endoscopic image and video data to create a deep learning-based automatic assisted diagnosis system, it is possible to increase the accuracy of the examination and treatment effect because artificial intelligence assists the doctor in diagnosing.
Director Yoo Gyeong-ho said, “We will create an innovative data ecosystem and use it as a nutrient for the future medical development with IT infrastructure, which is the special strength of Sungshim Hospital, and specialized medical big data of consortium hospitals.” “We will not spare any investment and support.”
Copyright holder © The Unauthorized Reproduction and Redistribution of the Medical Hyeopsis is prohibited.